Valeant Pharmaceuticals
MDT prepares $10B worth of bonds to help fund its $43B acquisition of COV | The week in medtech M&A
Ackman supports Allergan’s $66B sale to Actavis
UPDATE: Actavis trumps Valeant with $66B offer for Allergan
Source: Allergan near $66B buyout to escape Valeant, Ackman
Report: Actavis may buy Allergan for at least $60 billion
Medtronic inks package of loans worth more than $16 billion to back its $43 billion acquisition of Covidien | The week in medtech M&A
Salix inventory snafu sinks deal with Allergan
Allergan in talks with 3rd-party acquirer
Court leaves door open for Ackman’s vote at Allergan meeting
Ackman (Reuters/Eduardo Munoz).
Click to enlarge.
Allergan: We’ve been approached by 3rd party about a deal
